Companies

Phase Biolabs

phasebiolabs.com

Phase Biolabs retrofits industrial plants with fermentation technology that converts waste CO₂ into chemicals and e-fuels.

HQNottingham, Not applicable (non-US), United Kingdom
Employees1-50
1 active role
Jobs checked 4h ago
Energy / ClimateNot AIHardwareSeed

About

Phase Biolabs builds patented biotechnology and bolt-on fermentation systems that retrofit existing industrial plants, converting waste CO₂ into ethanol, chemicals, and e-fuels. Its customers are industrial plant operators and producers; its key differentiator is using emissions directly with minimal processing and without requiring carbon-capture technology, turning a waste stream into a revenue-generating asset.

Market

Phase Biolabs competes in industrial carbon capture, utilization and recycling, using synthetic biology and gas fermentation to convert industrial CO₂ into commodity chemicals, solvents, ethanol and e-fuels. Its positioning emphasizes a bolt-on retrofit for existing plants, direct use of emissions with minimal processing, and revenue generation from waste CO₂ rather than requiring a standalone carbon-capture system. The competitive set includes biological gas-fermentation companies such as LanzaTech and Arkeon, as well as adjacent CO₂-to-products platforms such as Twelve and Solugen.

Target Customers

Large industrial CO₂ emitters—especially existing bioethanol and chemical-manufacturing plants—that can install a separate retrofit unit and want to monetize emissions; likely buyers include plant owners, operations teams, and sustainability/decarbonization leaders. Secondary customers include chemical distributors and downstream manufacturers seeking low-carbon chemicals.

At a Glance

Problem

Phase Biolabs addresses the industrial problem of CO₂ emissions that are currently treated as a waste stream, cost, or compliance burden rather than as a feedstock. Its proposition is especially relevant to ethanol producers: much of the CO₂ generated by existing plants is vented, while producers face pressure to lower carbon intensity and secure better economics through advanced-biofuel pricing, low-carbon fuel credits, and emerging alcohol-to-jet markets.

The principal use case is retrofitting an existing grain-ethanol plant so its off-gas can be converted into additional ethanol. Phase’s illustrative model shows the potential economics: for a plant emitting 300,000 tonnes of CO₂ annually, the retrofit could produce 45 million additional gallons of ethanol and $42.3 million in modeled new revenue, assuming a $1.75-per-gallon ethanol price and including D5 RINs. These are company-model assumptions rather than demonstrated commercial results.

Product / Service

Phase develops a gas-fermentation platform using proprietary, genetically engineered microbial biocatalysts. Its three-step process prepares the gas, ferments the CO₂ into ethanol, and separates the product. The company says the process uses emissions directly with minimal processing, requires no separate carbon-capture technology, and can be installed as a bolt-on unit without disrupting the customer's existing plant.

The delivery model is a licensable retrofit: Phase licenses the technology and supplies the biocatalyst, while the industrial producer operates the production asset and retains the resulting output and upside. The benefit is a way to turn an emissions stream into more product and revenue while reducing process carbon intensity. Phase is also developing a broader platform for carbon-negative chemicals and e-fuels beyond its initial ethanol application.

Market

Phase competes in carbon capture and utilisation, industrial biotechnology, gas fermentation, low-carbon ethanol, and CO₂-derived fuels and chemicals. Its initial target market is sizeable by industrial standards: Phase says the global ethanol industry includes more than 800 plants, with the majority of their CO₂ currently vented. Relevant competitors and alternative approaches include LanzaTech, which uses gas fermentation to produce ethanol from industrial emissions and reports six commercial facilities, and Twelve, which converts CO₂ into products such as sustainable aviation fuel using renewable electricity.

Phase was founded in 2020, joined Y Combinator’s Winter 2022 batch, and reports support from Breakthrough Energy and Transition. It operates a small pilot plant in Nottingham, uses that facility to collect continuous performance data, and has reported pilot ethanol yields above 80%. It has partnership agreements involving biogenic CO₂ and renewable hydrogen and is seeking partners and a location for a commercial demonstration plant. The evidence therefore indicates a funded, pilot-stage and pre-commercial company rather than one with established commercial revenue or a full-scale operating plant.

Founders & Leadership

David OrtegaFounder
Founder & CEO

Funding History

2020-09
SBRI Phase 1 grant£40K

Innovate UK (SBRI)

2022-03
Seed$500K

Transition, Y Combinator

Recent News

2026-07-29product
So you want to use plants to reduce CO₂

A recent Hacker News discussion featuring Phase Biolabs describes a lab-scale 1.5L bioreactor containing a microorganism that consumes carbon dioxide and hydrogen gas. The available snippet truncates before identifying the resulting products.

2026-07-25
Climate Startups funded by Y Combinator (YC) 2026

Y Combinator’s 2026 climate-startup directory lists Phase Biolabs as developing carbon-negative solvents and electro-fuels from carbon dioxide using fermentation.

2026-04-10partnership
Welcome to Our New Member, Phase Biolabs!

CO2 Value Europe announced Phase Biolabs as a new member and described its focus on converting waste CO₂ into valuable chemicals and electrofuels through carbon capture and utilisation. The announcement says Phase Biolabs is seeking EU/UK partners and locations for a commercial demonstration plant.

2026
Model acetogens as chassis for CO2-driven bioproduction

A 2026 ScienceDirect paper identifies Phase Biolabs, alongside Again Bio and Electrochaea, as one of several companies pioneering CO₂ fermentation at different development stages.

Active Roles

1
Nottingham/Engineering/33d ago

Business Model

Phase Biolabs appears to pursue a B2B industrial-technology model, commercializing retrofit gas-fermentation systems for industrial plants through customer deployments and commercial partnerships. Its public materials do not disclose specific pricing, licensing terms, or recurring revenue arrangements.

Products

CO₂-to-ethanol gas-fermentation systemCO₂-derived carbon-neutral chemicals and solventsCO₂-derived carbon-neutral or carbon-negative e-fuels/electrofuelsTurn-key carbon-capture-utilization retrofit platform for existing industrial plants

Customers

Alcohols LimitedCambridge Display Technology

Tech Stack

Gas fermentationEngineered microbial biocatalystsSynthetic biology and genetic engineeringAI-assisted biocatalyst designDirect CO₂ utilization with minimal processingBolt-on industrial process integration

Competitors

LanzaTech
Solugen
Twelve
Arkeon Biotechnologies